Literature DB >> 33604756

GW-SEM 2.0: Efficient, Flexible, and Accessible Multivariate GWAS.

Joshua N Pritikin1,2, Michael C Neale1,2,3, Elizabeth C Prom-Wormley4, Shaunna L Clark5, Brad Verhulst6.   

Abstract

Most genome-wide association study (GWAS) analyses test the association between single-nucleotide polymorphisms (SNPs) and a single trait or outcome. While valuable second-step analyses of these associations (e.g., calculating genetic correlations between traits) are common, single-step multivariate analyses of GWAS data are rarely performed. This is unfortunate because multivariate analyses can reveal information which is irrevocably obscured in multi-step analysis. One simple example is the distinction between variance common to a set of measures, and variance specific to each. Neither GWAS of sum- or factor-scores, nor GWAS of the individual measures will deliver a clean picture of loci associated with each measure's specific variance. While multivariate GWAS opens up a broad new landscape of feasible and informative analyses, its adoption has been slow, likely due to the heavy computational demands and difficulties specifying models it requires. Here we describe GW-SEM 2.0, which is designed to simplify model specification and overcome the inherent computational challenges associated with multivariate GWAS. In addition, GW-SEM 2.0 allows users to accurately model ordinal items, which are common in behavioral and psychological research, within a GWAS context. This new release enhances computational efficiency, allows users to select the fit function that is appropriate for their analyses, expands compatibility with standard genomic data formats, and outputs results for seamless reading into other standard post-GWAS processing software. To demonstrate GW-SEM's utility, we conducted (1) a series of GWAS using three substance use frequency items from data in the UK Biobank, (2) a timing study for several predefined GWAS functions, and (3) a Type I Error rate study. Our multivariate GWAS analyses emphasize the utility of GW-SEM for identifying novel patterns of associations that vary considerably between genomic loci for specific substances, highlighting the importance of differentiating between substance-specific use behaviors and polysubstance use. The timing studies demonstrate that the analyses take a reasonable amount of time and show the cost of including additional items. The Type I Error rate study demonstrates that hypothesis tests for genetic associations with latent variable models follow the hypothesized uniform distribution. Taken together, we suggest that GW-SEM may provide substantially deeper insights into the underlying genomic architecture for multivariate behavioral and psychological systems than is currently possible with standard GWAS methods. The current release of GW-SEM 2.0 is available on CRAN (stable release) and GitHub (beta release), and tutorials are available on our github wiki ( https://jpritikin.github.io/gwsem/ ).

Entities:  

Keywords:  GWAS; Genetics; Genome-wide association study; SEM; Structural equation modeling; Weighted least squares

Mesh:

Year:  2021        PMID: 33604756     DOI: 10.1007/s10519-021-10043-1

Source DB:  PubMed          Journal:  Behav Genet        ISSN: 0001-8244            Impact factor:   2.805


  31 in total

1.  Genomic control for association studies.

Authors:  B Devlin; K Roeder
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

2.  Using human genetics to make new medicines.

Authors:  Jeffrey C Barrett; Ian Dunham; Ewan Birney
Journal:  Nat Rev Genet       Date:  2015-09-15       Impact factor: 53.242

3.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies.

Authors:  Brendan K Bulik-Sullivan; Po-Ru Loh; Hilary K Finucane; Stephan Ripke; Jian Yang; Nick Patterson; Mark J Daly; Alkes L Price; Benjamin M Neale
Journal:  Nat Genet       Date:  2015-02-02       Impact factor: 38.330

4.  NCAM1-TTC12-ANKK1-DRD2 variants and smoking motives as intermediate phenotypes for nicotine dependence.

Authors:  L C Bidwell; J E McGeary; J C Gray; R H C Palmer; V S Knopik; J MacKillop
Journal:  Psychopharmacology (Berl)       Date:  2014-10-03       Impact factor: 4.530

Review 5.  Precision medicine, genomics and drug discovery.

Authors:  Lon R Cardon; Tim Harris
Journal:  Hum Mol Genet       Date:  2016-08-18       Impact factor: 6.150

Review 6.  A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry.

Authors:  Laramie E Duncan; Matthew C Keller
Journal:  Am J Psychiatry       Date:  2011-09-02       Impact factor: 18.112

7.  An initial investigation of associations between dopamine-linked genetic variation and smoking motives in African Americans.

Authors:  L C Bidwell; J E McGeary; J C Gray; R H C Palmer; V S Knopik; J MacKillop
Journal:  Pharmacol Biochem Behav       Date:  2015-09-26       Impact factor: 3.533

8.  UK biobank data: come and get it.

Authors:  Naomi E Allen; Cathie Sudlow; Tim Peakman; Rory Collins
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

9.  Second-generation PLINK: rising to the challenge of larger and richer datasets.

Authors:  Christopher C Chang; Carson C Chow; Laurent Cam Tellier; Shashaank Vattikuti; Shaun M Purcell; James J Lee
Journal:  Gigascience       Date:  2015-02-25       Impact factor: 6.524

10.  An atlas of genetic correlations across human diseases and traits.

Authors:  Brendan Bulik-Sullivan; Hilary K Finucane; Verneri Anttila; Alexander Gusev; Felix R Day; Po-Ru Loh; Laramie Duncan; John R B Perry; Nick Patterson; Elise B Robinson; Mark J Daly; Alkes L Price; Benjamin M Neale
Journal:  Nat Genet       Date:  2015-09-28       Impact factor: 38.330

View more
  1 in total

1.  Clarifying the Genetic Influences on Nicotine Dependence and Quantity of Use in Cigarette Smokers.

Authors:  Brad Verhulst; Shaunna L Clark; Jingchun Chen; Hermine H Maes; Xiangning Chen; Michael C Neale
Journal:  Behav Genet       Date:  2021-04-21       Impact factor: 2.965

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.